Fractyl
Marc Elia is the founder of M28 Capital, a healthcare sector investment fund. Prior to that, from January 2012 to September 2019, Mr. Elia served as a partner at Bridger Capital, an investment fund. He is on the Board of Directors of Adagio Therapeutics, Adimab, and SQZ Biotechnologies.
Mr. Elia holds a B.A. in economics from Carleton College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices